Aphex™ BioCleanse Systems – Hydrogen Based Hand Sanitizer

David Weaver, CEO of Aphex™ BioCleanse Systems, Inc. discusses the world’s first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology. The technology, called Hy-IQ® Water, has a unique method of action that uses hydrogen ions traveling at nearly the speed of light to breach the cell walls of exoskeleton germs. The company has filed to be the first FDA cleared non-alcohol hand sanitizer.  Aphex has created other products that are safe for pets, can be used on vegetables and fruits, and in industrial and clinical settings.

Read More

Alliance for Endometriosis (U.S.)

Sarah Cross, Ph.D., Associate Scientific Director, Women’s Health, U.S. Medical Affairs at AbbVie discusses the newly formed Alliance for Endometriosis by seven women’s health-focused organizations – AbbVie, the American College of Obstetricians and Gynecologists, Black Women’s Health Imperative, the Endometriosis Association, GE Healthcare, Healthy Women and the International Pelvic Pain Society.  The goal of the alliance is to improve the lives of the one in 10 women of reproductive age living with endometriosis in the United States. The Alliance is actively seeking insights via a survey at AllianceForEndo.com and encouraging the endometriosis community to share their experiences to better understand their wants and needs.

Read More

SUTAB Tablets – New, Safe, Effective Alternative to Liquid Bowel Preparations

Dr. Douglas Rex, MD., Distinguished Professor Emeritus at Indiana University School of Medicine, discusses the recent (Nov 2020) U.S. FDA approval of Sebela Pharmaceuticals’ SUTAB® Tablets (sodium sulfate, magnesium sulfate, and potassium chloride), a new, safe, and effective alternative to liquid colonoscopy prep solution.  He worked as a lead principal investigator for the Phase 3 clinical trials of SUTAB

Read More

New Treatment for Primary Generalized Tonic-Clonic Seizures PGTCS

Lead researcher, Dr. David Vossler, MD, FAAN FACNS FAES, Department of Neurology, University of Washington, discusses the recent U.S. FDA approval of UCB’s VIMPAT® (lacosamide) CV as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older and VIMPAT injection for intravenous use in children four years of age and older.

Read More

The Holiday Season and Mental Health

Dr. Jessica Whelan, family psychiatric nurse practitioner discusses why the holiday season can be particularly challenging for people living with mental health conditions like bipolar I disorder, the difference between holiday blues and bipolar I disorder, and a treatment option people living with bipolar I disorder can discuss with their doctors. Visit www.vraylar.com to learn more including additional safety information.

Read More

COVID-19, Vitamin D deficiency , and Post-Viral Energy Depletion

Returning guest, board-certified internist, Dr. Jacob Teitelbaum discusses a recent study published in the “American Journal of Clinical Pathology” (Nov 2020) that showed that 59 percent of patients with COVID-19 are vitamin D-deficient when they’re admitted; and the deficiency was most pronounced in men with advanced stages of COVID-related pneumonia.  He also talks about the long term effects of COVID-19, known as “long-hauler syndrome” and his clinical work and research on post-viral energy depletion.

Read More

Underdiagnosed COPD

Dr. Riju Ray, MD, PhD, Senior Medical Lead at GSK, leading U.S. medical affairs across asthma and COPD, discusses a recent (Dec 2020) study funded by GSK and co-developed by GSK and CHEST as part of the CHEST “Clinical Perspectives” series evaluating the role of pulmonologists, COPD exacerbations, and the need to improve COPD management and education.

Read More